Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 13;3(9):1502-1510.
doi: 10.34067/KID.0001492022. eCollection 2022 Sep 29.

Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Intensive Care Unit Admission Diagnosis: A Prospective Cohort Study

Affiliations

Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Intensive Care Unit Admission Diagnosis: A Prospective Cohort Study

Goni Katz-Greenberg et al. Kidney360. .

Abstract

Background: Acute kidney injury (AKI) is most commonly caused by tubular injury and is associated with a wide variety of critical illnesses. It is well known that urinary biomarkers can lead to the early identification of AKI. However, the ability of urinary biomarkers to distinguish between different types of critical illness has been less studied.

Methods: In this prospective cohort study, urinary neutrophil gelatinase-associated lipocalin (uNGAL) was measured in 107 patients consecutively admitted to the ICUs in our tertiary medical center. uNGAL samples were collected within 3-6 hours of admission to an ICU and measured by ELISA. All data were analyzed using R statistical software, and univariate analysis was used to determine the correlations of uNGAL levels with AKI stage, admission diagnoses, and ICU course.

Results: uNGAL level increased by a mean of 24-fold (SD 10-59) in ICU patients with AKI and demonstrated a significant correlation with the different AKI stages. uNGAL predicted the need for RRT, with values increased by more than 15-fold (P<0.05) in patients needing RRT, and remained a useful tool to predict AKI in ICU patients with a urinary tract infection. uNGAL level was correlated with certain ICU admitting diagnoses whereby uNGAL levels were lower in ICU patients with cardiogenic shock compared with other admission diagnoses (β=-1.92, P<0.05).

Conclusions: uNGAL can be used as an early predictor of AKI and its severity in patients admitted to the ICU, including the need for RRT. uNGAL may also help in distinguishing patients with cardiogenic shock from those with other critical illnesses and identifying those at risk for poor outcomes irrespective of the presence of AKI.

Keywords: AKI; ICU nephrology; NGAL; acute kidney injury; acute kidney injury and ICU nephrology; cardiogenic shock; injury marker; lipocalin-2; sepsis; shock; urine biomarker.

PubMed Disclaimer

Conflict of interest statement

D.L. Broyles reports being an employer of Dennis Broyles IVD Consulting; consultancy for L3 Healthcare; and ownership interest in Beckman Coulter. M. Malinchoc reports being an employee of L3 Healthcare. D. Oxman reports that his spouse is a full-time employee of Merck working on pediatric vaccines. She works on a number of clinical trials sponsored by Merck. None of these trials have anything to do with the contents of the submitted manuscript. All remaining authors have nothing to disclose.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Comparison of urinary neutrophil gelatinase–associated lipocalin (uNGAL) value at intensive care unit (ICU) admission by AKI stage. P<0.001.
Figure 2.
Figure 2.
uNGAL levels at ICU admission in non-AKI and AKI groups. (A) Non-AKI: (left) uNGAL levels in various ICU admission groups in patients without AKI; (right) logarithmic scale of uNGAL levels. *P<0.05 compared with the admission diagnosis: cardiogenic shock. (B) AKI: (left) uNGAL levels in various ICU admission groups in patients with AKI; (right) logarithmic scale of uNGAL levels. *P<0.05 compared with the admission diagnosis: cardiogenic shock.
Figure 3.
Figure 3.
Admission uNGAL values for ICU patients without AKI or with various stages of AKI stratified by admitting diagnosis. ANOVA comparison of the groups. *AKI stage versus no AKI; P<0.01.
Figure 4.
Figure 4.
Differential uNGAL values in patients needing RRT or with UTI. Admission uNGAL value plotted against (A) RRT initiation (*P<0.05) and (B) incidence of urinary tract infection (*P<0.05).

References

    1. Lameire N, Hoste E: Reflections on the definition, classification, and diagnostic evaluation of acute renal failure. Curr Opin Crit Care 10: 468–475, 2004. 10.1097/01.ccx.0000144939.24897.71 - DOI - PubMed
    1. Star RA: Treatment of acute renal failure. Kidney Int 54: 1817–1831, 1998. 10.1046/j.1523-1755.1998.00210.x - DOI - PubMed
    1. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534–2543, 2003. 10.1097/01.ASN.0000088027.54400.C6 - DOI - PubMed
    1. Bouchard J, Acharya A, Cerda J, Maccariello ER, Madarasu RC, Tolwani AJ, Liang X, Fu P, Liu ZH, Mehta RL: A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10: 1324–1331, 2015. 10.2215/CJN.04360514 - DOI - PMC - PubMed
    1. Yuen PS, Jo SK, Holly MK, Hu X, Star RA: Ischemic and nephrotoxic acute renal failure are distinguished by their broad transcriptomic responses. Physiol Genomics 25: 375–386, 2006. 10.1152/physiolgenomics.00223.2005 - DOI - PMC - PubMed